# RefleXion PET/CT Imaging Performance in Patients With Prostate Cancer

> **NCT05470699** · NA · ACTIVE_NOT_RECRUITING · sponsor: **City of Hope Medical Center** · enrollment: 34 (actual)

## Conditions studied

- Prostate Carcinoma

## Interventions

- **PROCEDURE:** Computed Tomography
- **OTHER:** Fluorine F 18 Piflufolastat
- **DEVICE:** Positron Emission Tomography

## Key facts

- **NCT ID:** NCT05470699
- **Lead sponsor:** City of Hope Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-08-29
- **Primary completion:** 2023-03-29
- **Final completion:** 2026-04-13
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2025-12-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05470699

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05470699, "RefleXion PET/CT Imaging Performance in Patients With Prostate Cancer". Retrieved via AI Analytics 2026-08-08 from https://api.ai-analytics.org/clinical/NCT05470699. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*